Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Q2 2020 Takeda Pharmaceutical Co Ltd Earnings Call Transcript

Oct 31, 2019 / 12:00PM GMT
Release Date Price: $17.97 (-0.55%)
Operator

Good day, everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. This conference call may contain forward-looking statements, beliefs or opinions regarding Takeda's future business; future position; and the results of operations, including estimates, forecasts, targets and plans of Takeda. Any forward-looking statements in this conference call are based on the current assumptions and beliefs of Takeda in light of the information currently available to it. Such forward-looking statements do not represent any guarantee by Takeda or its management of future performance and involve known and unknown risks, uncertainties and other factors. (Operator Instructions)

Now we start the conference. Mr. Okubo, please go ahead.

Takashi Okubo
Takeda Pharmaceutical Company Limited - Global Head of IR, Global Finance

Good morning, good afternoon, good evening. Thank you very much for your participating in the conference call of Takeda's second quarter financial results for fiscal 2019.

Now I would like to introduce today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot